Theranostics nuclear medicine in prostate cancer (2024)
Fonte: Pharmaceuticals. Unidade: IQSC
Assuntos: MEDICINA NUCLEAR, NEOPLASIAS, PRÓSTATA
ABNT
LIMA, Helena et al. Theranostics nuclear medicine in prostate cancer. Pharmaceuticals, v. 17, n. 11, p. 1483, 2024Tradução . . Disponível em: https://doi.org/10.3390/ph17111483. Acesso em: 08 out. 2025.APA
Lima, H., Etchebehere, M., Bogoni, M., Torricelli, C., Lima, E. N., Deflon, V. M., et al. (2024). Theranostics nuclear medicine in prostate cancer. Pharmaceuticals, 17( 11), 1483. doi:10.3390/ph17111483NLM
Lima H, Etchebehere M, Bogoni M, Torricelli C, Lima EN, Deflon VM, Lima M, Etchebehere E. Theranostics nuclear medicine in prostate cancer [Internet]. Pharmaceuticals. 2024 ; 17( 11): 1483.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ph17111483Vancouver
Lima H, Etchebehere M, Bogoni M, Torricelli C, Lima EN, Deflon VM, Lima M, Etchebehere E. Theranostics nuclear medicine in prostate cancer [Internet]. Pharmaceuticals. 2024 ; 17( 11): 1483.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ph17111483